Please assess the completion status of the following clinical trial:

Trial Title: Artificial Valve Endocarditis Reduction Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patient requires an isolated mitral, isolated aortic, or double (aortic and mitral) valve replacement~* The patient is a candidate to receive an SJM (St. Jude Medical) Masters Series valve(s) with either the conventional cuff or the cuff with Silzone coating~* The patient (or legal guardian) has signed a study-specific consent form agreeing to the randomization, data collection, and follow-up requirements~Exclusion Criteria:~* The patient has a medical condition which contraindicates implantation of the SJM Masters Series with Silzone coating~* The patient already has a prosthetic valve other than the valve being replaced at this time~* The patient requires a tricuspid valve replacement

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- St. Jude Medical (SJM) Conventional (Type: OTHER): St. Jude Medical (SJM) Standard Masters Series Mechanical Heart Valve with Conventional Cuff
- St. Jude Medical (SJM) Silzone (Type: OTHER): St. Jude Medical (SJM) Masters Series Mechanical Heart Valve with Silzone Coating

Based on this trial design, predict the completion outcome and termination type (if applicable).